Who: Researchers in academia, government, and industry, nationally or internationally. A list of highly ranked applications can be found here.
What: Drug discovery and development projects will enter an NCI pipeline focused on unmet needs in therapeutics that are not adequately addressed by the private sector. The NCI is committed to moving high-priority discovery and development projects through to proof-of-concept clinical trials. For more information, visit About NExT.
What NExT is not: NExT is not a grant or contract mechanism. Rather, approved projects for the NCI pipeline will be provided access to the Institute's drug discovery and preclinical and clinical development resources.
When: Submission deadlines occur three times per year.
Where: Online submission of NExT application.
How: Entry into NExT can occur at any stage of the drug discovery or development pipeline, but depends on favorable review of the application's scientific merit. For more information, visit How to Apply. Approved discovery and preclinical development activities may be performed by the NCI Chemical Biology Consortium, a component of NExT.
Sponsors: NCI's Division of Cancer Treatment and Diagnosis and Center for Cancer Research.